Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126479232 | 12647923 | 2 | F | 20160802 | 20160812 | 20160812 | EXP | EE-SA-2016SA142868 | AVENTIS | LASS J, TAMME K, IRS A. DOSING OF MEDICINES IN A SUPEROBESE PATIENT: A CLINICAL CASE. EESTI ARST. 2016;95(1):38-44. | 54.00 | YR | A | M | Y | 250.00000 | KG | 20160812 | OT | EE | EE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126479232 | 12647923 | 1 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | UNK | 0 | 2 | G | TID | |||||||
| 126479232 | 12647923 | 2 | PS | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | Unknown | UNK | 20164 | 40 | MG | QD | |||||||
| 126479232 | 12647923 | 3 | SS | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | Unknown | UNK | 20164 | 60 | MG | QD | |||||||
| 126479232 | 12647923 | 4 | SS | ENOXAPARIN SODIUM. | ENOXAPARIN SODIUM | 1 | Unknown | UNK | 20164 | 100 | MG | QD | |||||||
| 126479232 | 12647923 | 5 | C | CEFUROXIME. | CEFUROXIME | 1 | 0 | 1.5 | G | TID | |||||||||
| 126479232 | 12647923 | 6 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | 0 | 500 | MG | BID | |||||||||
| 126479232 | 12647923 | 7 | C | OSELTAMIVIR | OSELTAMIVIR | 1 | 0 | 150 | MG | BID | |||||||||
| 126479232 | 12647923 | 8 | C | TAZOBACTAM/PIPERACILLIN | 2 | 0 | 4.5 | G | TID | ||||||||||
| 126479232 | 12647923 | 9 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 0 | 500 | MG | TID | |||||||||
| 126479232 | 12647923 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 20 | MG | CAPSULE | QD | ||||||||
| 126479232 | 12647923 | 11 | C | METOPROLOL. | METOPROLOL | 1 | POLONGED-RELEASE | 0 | 50 | MG | TABLET | QD | |||||||
| 126479232 | 12647923 | 12 | C | AMIODARONE | AMIODARONE | 1 | 0 | 200 | MG | TABLET | QD | ||||||||
| 126479232 | 12647923 | 13 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | 1.25 | MG | TABLET | QD | ||||||||
| 126479232 | 12647923 | 14 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | 25 | MG | TABLET | QD | ||||||||
| 126479232 | 12647923 | 15 | C | RIVAROXABAN | RIVAROXABAN | 1 | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126479232 | 12647923 | 1 | Infection |
| 126479232 | 12647923 | 2 | Thrombosis prophylaxis |
| 126479232 | 12647923 | 3 | Thrombosis prophylaxis |
| 126479232 | 12647923 | 4 | Thrombosis prophylaxis |
| 126479232 | 12647923 | 5 | Pneumonia |
| 126479232 | 12647923 | 6 | Pneumonia |
| 126479232 | 12647923 | 7 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126479232 | 12647923 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126479232 | 12647923 | Atrial fibrillation | |
| 126479232 | 12647923 | Drug ineffective | |
| 126479232 | 12647923 | Hepatic failure | |
| 126479232 | 12647923 | Obstructive shock | |
| 126479232 | 12647923 | Overdose | |
| 126479232 | 12647923 | Product use issue | |
| 126479232 | 12647923 | Pulmonary embolism | |
| 126479232 | 12647923 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |